Cuiqing Zhao, Liming Liu, Qi Liu, Fengyuan Li, Lihua Zhang, Fenxia Zhu, . . . Wenke Feng. (2019). Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice. Elsevier.
Chicago Style (17th ed.) CitationCuiqing Zhao, et al. Fibroblast Growth Factor 21 Is Required for the Therapeutic Effects of Lactobacillus Rhamnosus GG Against Fructose-induced Fatty Liver in Mice. Elsevier, 2019.
MLA (9th ed.) CitationCuiqing Zhao, et al. Fibroblast Growth Factor 21 Is Required for the Therapeutic Effects of Lactobacillus Rhamnosus GG Against Fructose-induced Fatty Liver in Mice. Elsevier, 2019.
Warning: These citations may not always be 100% accurate.